Published in Am J Respir Crit Care Med on January 14, 2010
Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications | NCT00557180
Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med (2011) 3.00
Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit Care Med (2012) 1.88
Vitamin D deficiency, smoking, and lung function in the Normative Aging Study. Am J Respir Crit Care Med (2012) 1.75
Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clin Exp Allergy (2013) 1.70
Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA (2014) 1.67
The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res (2011) 1.65
Cluster analysis of obesity and asthma phenotypes. PLoS One (2012) 1.56
Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care (2011) 1.52
Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One (2012) 1.47
Vitamin D and asthma. Am J Respir Crit Care Med (2011) 1.44
The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med (2013) 1.36
The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol (2012) 1.27
Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J Allergy Clin Immunol (2012) 1.22
Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma. Respiration (2010) 1.13
Vitamin D effects on lung immunity and respiratory diseases. Vitam Horm (2011) 1.12
Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr (2011) 1.12
Vitamin D in inflammatory diseases. Front Physiol (2014) 1.10
A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women. Nutr J (2012) 1.06
Vitamin d and susceptibility of chronic lung diseases: role of epigenetics. Front Pharmacol (2011) 1.03
Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun (2011) 1.00
Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol (2012) 0.98
Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease. Allergy (2014) 0.97
Calcitriol decreases expression of importin α3 and attenuates RelA translocation in human bronchial smooth muscle cells. J Clin Immunol (2012) 0.94
Asthma prevalence associated with geographical latitude and regional insolation in the United States of America and Australia. PLoS One (2011) 0.94
Vitamin D and asthma. Dermatoendocrinol (2012) 0.94
Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract (2013) 0.92
Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation. Exp Mol Pathol (2012) 0.92
Inhaled corticosteroids in lung diseases. Am J Respir Crit Care Med (2013) 0.91
Vitamin D enhances glucocorticoid action in human monocytes: involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14. J Biol Chem (2013) 0.91
Reversible control by vitamin D of granulocytes and bacteria in the lungs of mice: an ovalbumin-induced model of allergic airway disease. PLoS One (2013) 0.91
Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms. J Biol Chem (2011) 0.91
Vitamin D deficiency and the lung: disease initiator or disease modifier? Nutrients (2013) 0.90
Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency. Respir Res (2013) 0.89
Outdoor exposure and vitamin D levels in urban children with asthma. Nutr J (2013) 0.89
Obesity, Nutrition, and Asthma in Children. Pediatr Allergy Immunol Pulmonol (2012) 0.89
Vitamin D deficiency causes airway hyperresponsiveness, increases airway smooth muscle mass, and reduces TGF-β expression in the lungs of female BALB/c mice. Physiol Rep (2014) 0.89
Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC Med Genet (2011) 0.88
Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-γ(high) immunophenotypes: Potential benefits of calcitriol. J Allergy Clin Immunol (2015) 0.88
Hematopoietic stem and progenitor cells in inflammation and allergy. Front Immunol (2013) 0.87
Asthma in the elderly: a study of the role of vitamin D. Allergy Asthma Clin Immunol (2014) 0.87
Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 0.87
Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies. Lung (2014) 0.87
Vitamin D and the development of allergic disease: how important is it? Clin Exp Allergy (2015) 0.86
Diet and asthma: vitamins and methyl donors. Lancet Respir Med (2013) 0.86
Relationship of maternal vitamin D level with maternal and infant respiratory disease. Am J Obstet Gynecol (2011) 0.86
The effect of vitamin d status on pediatric asthma at a university hospital, Thailand. Allergy Asthma Immunol Res (2013) 0.85
Link between vitamin D and airway remodeling. J Asthma Allergy (2014) 0.85
Vitamin D attenuates cytokine-induced remodeling in human fetal airway smooth muscle cells. J Cell Physiol (2015) 0.84
Vitamin D supplementation blocks pulmonary structural and functional changes in a rat model of perinatal vitamin D deficiency. Am J Physiol Lung Cell Mol Physiol (2014) 0.83
Serum 25-hydroxy-vitamin D and ionised calcium in relation to lung function and allergen skin tests. Eur J Clin Nutr (2011) 0.83
Lipopolysaccharide-induced lung injury is independent of serum vitamin D concentration. PLoS One (2012) 0.83
Vitamin E and D regulation of allergic asthma immunopathogenesis. Int Immunopharmacol (2014) 0.82
Mechanism of action of vitamin D in the asthmatic lung. J Investig Med (2011) 0.82
Relationship of adipokines with immune response and lung function in obese asthmatic and non-asthmatic women. J Asthma (2011) 0.82
Bronchial asthma and hypovitaminosis D in Saudi children. Asia Pac Allergy (2015) 0.82
Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma. J Allergy Clin Immunol (2014) 0.82
Obesity, metabolic dysregulation and oxidative stress in asthma. Biochim Biophys Acta (2011) 0.81
Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. Chest (2010) 0.81
Vitamin D treatment modulates organic dust-induced cellular and airway inflammatory consequences. J Biochem Mol Toxicol (2012) 0.81
Update in asthma 2010. Am J Respir Crit Care Med (2011) 0.81
Vitamin D Inhibits Expression and Activity of Matrix Metalloproteinase in Human Lung Fibroblasts (HFL-1) Cells. Tuberc Respir Dis (Seoul) (2014) 0.81
Fat-soluble vitamins and atopic disease: what is the evidence? Proc Nutr Soc (2011) 0.81
A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis. J Res Pharm Pract (2016) 0.80
Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells. Infect Immun (2012) 0.80
Vitamin D, allergies and asthma: focus on pediatric patients. World Allergy Organ J (2014) 0.80
1,25D3 prevents CD8(+)Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoter. Nat Commun (2016) 0.80
Vitamin D in asthma and future perspectives. Drug Des Devel Ther (2013) 0.80
Vitamin D Insufficiency and Asthma in a US Nationwide Study. J Allergy Clin Immunol Pract (2016) 0.79
Vitamin D and asthma-life after VIDA? Curr Allergy Asthma Rep (2014) 0.79
Vitamin D supplementation protects against bone loss following inhalant organic dust and lipopolysaccharide exposures in mice. Immunol Res (2015) 0.79
The role of Vitamin D level and related single nucleotide polymorphisms in Crohn's disease. Nutrients (2013) 0.79
High Dose Vitamin D Administration in Ventilated Intensive Care Unit Patients: A Pilot Double Blind Randomized Controlled Trial. J Clin Transl Endocrinol (2016) 0.78
Conserved steroid hormone homology converges on nuclear factor κB to modulate inflammation in asthma. J Investig Med (2012) 0.78
Vitamin d insufficiency and asthma severity in adults from costa rica. Allergy Asthma Immunol Res (2013) 0.78
Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics. PLoS One (2015) 0.78
Preliminary evidence for vitamin D deficiency in nodulocystic acne. Dermatoendocrinol (2015) 0.78
Inhibition of vitamin d receptor translocation by cigarette smoking extracts. Tuberc Respir Dis (Seoul) (2012) 0.78
25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airways. Mediators Inflamm (2014) 0.78
Integrative medicine is integral to providing patient-centered care. Ann Allergy Asthma Immunol (2015) 0.77
Vitamin D deficiency is associated with impaired disease control in asthma-COPD overlap syndrome patients. Int J Chron Obstruct Pulmon Dis (2015) 0.76
Asthma and obesity: mechanisms and clinical implications. Asthma Res Pract (2015) 0.75
Asthma in sickle cell disease: implications for treatment. Anemia (2011) 0.75
Hypovitaminosis D: a novel finding in primary ciliary dyskinesia. Ital J Pediatr (2015) 0.75
Vitamin D and Asthma: Association, Causality, or Intervention? Pediatr Allergy Immunol Pulmonol (2015) 0.75
House dust mite induced lung inflammation does not alter circulating vitamin D levels. PLoS One (2014) 0.75
Treatment with 1,25(OH)2D3 induced HDAC2 expression and reduced NF-κB p65 expression in a rat model of OVA-induced asthma. Braz J Med Biol Res (2015) 0.75
Heterogeneity of glucocorticoid resistance in patients with bronchial asthma. Int J Biomed Sci (2010) 0.75
Vitamin D and Its Role as a Protective Factor in Allergy. Int Sch Res Notices (2014) 0.75
Inflammatory bowel disease and airway diseases. World J Gastroenterol (2016) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med (1999) 29.97
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09
Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13
Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr (2005) 6.32
Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol (2008) 5.37
Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med (2006) 4.83
Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med (2009) 4.64
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med (1999) 4.45
Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med (2007) 3.95
Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41
Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab (2003) 3.22
The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab (2004) 3.13
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest (2005) 2.94
Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest (1985) 2.61
Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest (1984) 2.43
Influence of body mass index on the response to asthma controller agents. Eur Respir J (2006) 2.41
1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest (1984) 2.39
Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J (2001) 2.39
The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem (2004) 2.22
Molecular mechanisms of corticosteroid resistance. Chest (2008) 2.06
Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol (2004) 2.00
Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest (1994) 1.98
Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med (2008) 1.68
Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond) (2008) 1.58
Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol (2009) 1.43
MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J Endocrinol (2003) 1.38
Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res (2001) 1.35
Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med (2007) 1.28
Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol (2007) 1.13
Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med (2002) 9.01
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41
Filaggrin mutations associated with skin and allergic diseases. N Engl J Med (2011) 3.40
Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity (2006) 3.39
Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol (2010) 3.22
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2007) 2.79
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev (2011) 2.62
Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol (2012) 2.27
Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol (2010) 2.20
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol (2009) 2.20
Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol (2004) 2.16
Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol (2006) 2.08
Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol (2003) 2.05
Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol (2004) 2.00
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol (2009) 2.00
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants. J Allergy Clin Immunol (2010) 1.97
Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol (2006) 1.88
Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol (2007) 1.85
Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol (2005) 1.78
Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol (2010) 1.77
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol (2007) 1.77
Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med (2008) 1.68
Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol (2003) 1.66
Smallpox vaccination: Risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol (2002) 1.60
Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol (2007) 1.57
Cluster analysis of obesity and asthma phenotypes. PLoS One (2012) 1.56
IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol (2007) 1.55
Ceragenins: a class of antiviral compounds to treat orthopox infections. J Invest Dermatol (2009) 1.55
Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol (2005) 1.54
Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med (2005) 1.53
IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol (2010) 1.49
10. Atopic dermatitis. J Allergy Clin Immunol (2006) 1.48
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
The role of allergens in asthma. Am Fam Physician (2007) 1.47
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2007. J Allergy Clin Immunol (2008) 1.46
Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol (2008) 1.44
Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin North Am (2010) 1.43
Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol (2010) 1.42
Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol (2006) 1.40
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2009) 1.38
Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol (2010) 1.38
IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol (2006) 1.37
T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol (2004) 1.36
The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med (2013) 1.36
The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol (2007) 1.32
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol (2011) 1.30
Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics (2003) 1.30
Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep (2006) 1.29
Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol (2008) 1.27
Allergic skin diseases. J Allergy Clin Immunol (2009) 1.25
Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol (2010) 1.25
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med (2012) 1.23
Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proc Natl Acad Sci U S A (2009) 1.23
Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry (2002) 1.23
Timing of initial exposure to cereal grains and the risk of wheat allergy. Pediatrics (2006) 1.22
Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J Allergy Clin Immunol (2012) 1.22
Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis (2008) 1.22
TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier. J Invest Dermatol (2011) 1.18
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol (2008) 1.17
Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol (2008) 1.15
Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol (2005) 1.14
A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. J Immunol (2002) 1.13
Characterization of Staphylococcus aureus enterotoxin L. Infect Immun (2003) 1.13
Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol (2007) 1.13
Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol (2006) 1.11
Vitamin D and food allergy in patients with severe atopic dermatitis. J Allergy Clin Immunol (2013) 1.10
Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation. J Biol Chem (2009) 1.10
Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol (2006) 1.09
Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J Allergy Clin Immunol (2011) 1.08
Renaissance of the hygiene hypothesis. J Allergy Clin Immunol (2006) 1.07
Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation. J Allergy Clin Immunol (2007) 1.05
Role of bacterial superantigens in atopic dermatitis : implications for future therapeutic strategies. Am J Clin Dermatol (2006) 1.05
Immunopathology of atopic dermatitis. J Allergy Clin Immunol (2006) 1.05
Oral food challenges in children with a diagnosis of food allergy. J Pediatr (2010) 1.03
Atopic dermatitis. J Allergy Clin Immunol (2006) 1.02
Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol (2006) 1.02
Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol (2009) 1.02
Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. J Mol Biol (2007) 1.01
Racial differences in T-lymphocyte response to glucocorticoids. Chest (2005) 1.01
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol (2011) 1.01
IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance. Am J Respir Cell Mol Biol (2008) 1.00
Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. Am J Respir Cell Mol Biol (2002) 1.00
The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am (2010) 0.98
Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol (2012) 0.98